#  Simon Moroney, D.Phil. 

###  Board member since 2020 | Vice-Chair since 2022 

 

 ![Simon Moroney, D.Phil., Board vice-chair](/sites/novartis_com/files/styles/biography_detail_image_v2/public/2026-06/simon-moroney-bio-1170.jpg?h=4cf895d5&itok=Tck-TlOo "Simon Moroney, D.Phil., Board vice-chair") 

 

 

**Nationality**: German/New Zealander | **Year of birth**: 1959

As co-founder and CEO of MorphoSys AG, Simon Moroney played a central role in establishing the company as a force in the field of therapeutic antibodies, with one of the broadest pipelines of drug candidates in the industry. Mr. Moroney holds both a doctorate and a Master’s degree in chemistry.

### Professional experience

- Co-founder and CEO, MorphoSys AG, Germany (1992-2019)
- Research associate, Department of Pharmacology, University of Cambridge, UK (1991-1992)
- Assistant professor, Department of Chemistry, University of British Columbia, Canada (1989-1990)

### Mandates

##### Current:

- Board chair and chair of the remuneration and nomination committee, Biotalys NV, Belgium

### Education

- Doctorate in chemistry, University of Oxford, UK
- Master’s degree in chemistry, University of Waikato, New Zealand

### Key skills

- Medicine/healthcare/R&D
- Environmental, social and governance (ESG)
- Leadership/management
- Regulatory/risk management



 



 

 

 



 

 



##  Novartis media library assets 

 [ 

 ![Simon Moroney, D.Phil., Board vice-chair](/sites/novartis_com/files/styles/cards_1_3/public/2026-06/simon-moroney-media-library-1.jpg.webp?itok=4sqPl6Kc "Simon Moroney, D.Phil., Board vice-chair") 

 

###  Simon Moroney, D.Phil. 

Board member | Vice-Chair

 

 

 ](/news/media-library/simon-moroney-dphil-0) [ 

 ![Simon Moroney, D.Phil., Board vice-chair](/sites/novartis_com/files/styles/cards_1_3/public/2026-06/simon-moroney-media-library-2.jpg.webp?itok=rH7vYKTX "Simon Moroney, D.Phil., Board vice-chair") 

 

###  Simon Moroney, D.Phil. 

Board member | Vice-Chair

 

 

 ](/news/media-library/simon-moroney-dphil-1)